In Situ Proteomic Analysis of Human Breast Cancer Epithelial Cells Using Laser Capture Microdissection: Annotation by Protein Set Enrichment Analysis and Gene Ontology

被引:61
作者
Cha, Sangwon [3 ]
Imielinski, Marcin B. [1 ,2 ]
Rejtar, Tomas [3 ]
Richardson, Elizabeth A. [1 ,2 ]
Thakur, Dipak [3 ]
Sgroi, Dennis C. [1 ,2 ]
Karger, Barry L.
机构
[1] Massachusetts Gen Hosp, Mol Pathol Unit, Charlestown, MA 02129 USA
[2] Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA 02129 USA
[3] Northeastern Univ, Barnett Inst, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
TRANSFER-RNA SYNTHETASES; NF-KAPPA-B; PROLIFERATOR-ACTIVATED RECEPTOR; SERUM RESPONSE FACTOR; ESTROGEN-RECEPTOR; TRANSCRIPTION FACTORS; EXPRESSION PROFILES; SHOTGUN PROTEOMICS; MASS-SPECTROMETRY; DUCTAL CARCINOMA;
D O I
10.1074/mcp.M110.000398
中图分类号
Q5 [生物化学];
学科分类号
070307 [化学生物学];
摘要
Identification of molecular signatures that allow detection of the transition from normal breast epithelial cells to malignant invasive cells is a critical component in the development of diagnostic, therapeutic, and preventative strategies for human breast cancer. Substantial efforts have been devoted to deciphering breast cancer etiology at the genome level, but only a limited number of studies have appeared at the proteome level. In this work, we compared individual in situ proteome profiles of nonpatient matched nine noncancerous, normal breast epithelial (NBE) samples with nine estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples by combining laser capture microdissection (LCM) and quantitative shotgun proteomics. A total of 12,970 unique peptides were identified from the 18 samples, and 1623 proteins were selected for quantitative analysis using spectral index (SpI) as a measure of protein abundance. A total of 298 proteins were differentially expressed between NBE and MBE at 95% confidence level, and this differential expression correlated well with immunohistochemistry (IHC) results reported in the Human Protein Atlas (HPA) database. To assess pathway level patterns in the observed expression changes, we developed protein set enrichment analysis (PSEA), a modification of a well-known approach in gene expression analysis, Gene Set Enrichment Analysis (GSEA). Unlike single gene-based functional term enrichment analyses that only examines pathway overrepresentation of proteins above a given significance threshold, PSEA applies a weighted running sum statistic to the entire expression data to discover significantly enriched protein groups. Application of PSEA to the expression data in this study revealed not only well-known ER-dependent and cellular morphology-dependent protein abundance changes, but also significant alterations of downstream targets for multiple transcription factors (TFs), suggesting a role for specific gene regulatory pathways in breast tumorigenesis. A parallel GOMiner analysis revealed both confirmatory and complementary data to PSEA. The combination of the two annotation approaches yielded extensive biological feature mapping for in depth analysis of the quantitative proteomic data. Molecular & Cellular Proteomics 9:2529-2544, 2010.
引用
收藏
页码:2529 / 2544
页数:16
相关论文
共 79 条
[1]
Interaction of vault particles with estrogen receptor in the MCF-7 breast cancer cell [J].
Abbondanza, C ;
Rossi, V ;
Roscigno, A ;
Gallo, L ;
Belsito, A ;
Piluso, G ;
Medici, N ;
Nigro, V ;
Molinari, AM ;
Moncharmont, B ;
Puca, GA .
JOURNAL OF CELL BIOLOGY, 1998, 141 (06) :1301-1310
[2]
Molecular characterization of the tumor microenvironment in breast cancer [J].
Allinen, M ;
Beroukhim, R ;
Cai, L ;
Brennan, C ;
Lahti-Domenici, J ;
Huang, HY ;
Porter, D ;
Hu, M ;
Chin, L ;
Richardson, A ;
Schnitt, S ;
Sellers, WR ;
Polyak, K .
CANCER CELL, 2004, 6 (01) :17-32
[3]
The mechanisms of action of PPARs [J].
Berger, J ;
Moller, DE .
ANNUAL REVIEW OF MEDICINE, 2002, 53 :409-435
[4]
A Genecentric Human Protein Atlas for Expression Profiles Based on Antibodies [J].
Berglund, Lisa ;
Bjoerling, Erik ;
Oksvold, Per ;
Fagerberg, Linn ;
Asplund, Anna ;
Szigyarto, Cristina Al-Khalili ;
Persson, Anja ;
Ottosson, Jenny ;
Wernerus, Henrik ;
Nilsson, Peter ;
Lundberg, Emma ;
Sivertsson, Asa ;
Navani, Sanjay ;
Wester, Kenneth ;
Kampf, Caroline ;
Hober, Sophia ;
Ponten, Fredrik ;
Uhlen, Mathias .
MOLECULAR & CELLULAR PROTEOMICS, 2008, 7 (10) :2019-2027
[5]
BERGSTRAESSER LM, 1995, AM J PATHOL, V147, P1823
[6]
Proteomics of breast cancer - Principles and potential clinical applications [J].
Bertucci, Francois ;
Birnbaum, Daniel ;
Goncalves, Anthony .
MOLECULAR & CELLULAR PROTEOMICS, 2006, 5 (10) :1772-1786
[7]
TP53 and breast cancer [J].
Borresen-Dale, AL .
HUMAN MUTATION, 2003, 21 (03) :292-300
[8]
Molecular classification and molecular forecasting of breast cancer: Ready for clinical application? [J].
Brenton, JD ;
Carey, LA ;
Ahmed, AA ;
Caldas, C .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (29) :7350-7360
[9]
Inhibition of transforming growth factor β-enhanced serum response factor-dependent transcription by SMAD7 [J].
Camoretti-Mercado, Blanca ;
Fernandes, Darren J. ;
Dewundara, Samantha ;
Churchill, Jason ;
Ma, Lan ;
Kogut, Paul C. ;
McConville, John F. ;
Parmacek, Michael S. ;
Solway, Julian .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (29) :20383-20392
[10]
Genomic and transcriptional aberrations linked to breast cancer pathophysiologies [J].
Chin, Koei ;
DeVries, Sandy ;
Fridlyand, Jane ;
Spellman, Paul T. ;
Roydasgupta, Ritu ;
Kuo, Wen-Lin ;
Lapuk, Anna ;
Neve, Richard M. ;
Qian, Zuwei ;
Ryder, Tom ;
Chen, Fanqing ;
Feiler, Heidi ;
Tokuyasu, Taku ;
Kingsley, Chris ;
Dairkee, Shanaz ;
Meng, Zhenhang ;
Chew, Karen ;
Pinkel, Daniel ;
Jain, Ajay ;
Ljung, Britt Marie ;
Esserman, Laura ;
Albertson, Donna G. ;
Waldman, Frederic M. ;
Gray, Joe W. .
CANCER CELL, 2006, 10 (06) :529-541